Cargando…

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial

Detalles Bibliográficos
Autores principales:	Schmoll, H, Wittig, BW, Arnold, DA, Riera-Knorrenschild, JRK, Nietsche, DN, Kroening, HK, Mayer, FM, Andel, JA, Ziebermayr, RZ, Scheithauer, WS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072008/ http://dx.doi.org/10.1186/2051-1426-2-S2-I2

Ejemplares similares

Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial
por: Schmoll, Hans-Joachim, et al.
Publicado: (2014)

Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703
por: Schmidt, Manuel, et al.
Publicado: (2015)

TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes
por: Schleimann, Mariane H., et al.
Publicado: (2019)

The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon
por: Krarup, Astrid Raaby, et al.
Publicado: (2017)

Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study
por: Stein, Alexander, et al.
Publicado: (2015)

S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Cojocaru, G, et al.
Publicado: (2014)

S82. Proffered paper: In-vivo testing of PSMA-targeted T-cell immunotherapy for prostate cancer
por: Liu, Z, et al.
Publicado: (2014)

S50. Proffered paper: Complex tumour microenvironment screening platform captures biological responses of cancer therapeutics
por: Layman, H, et al.
Publicado: (2014)

S77. Proffered paper: In vitro induced response patterns of antileukemic T-cells – characterization by combination of functional assays, spectratyping and next generation sequencing
por: Reuther, S, et al.
Publicado: (2014)

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
por: Grassmann, S, et al.
Publicado: (2014)

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data
por: Shevtsov, M, et al.
Publicado: (2014)

S78. Proffered paper: High-affinity CD20-specific TCRs suitable for adoptive immunotherapy can be readily isolated from the allo-repertoire using reverse immunology
por: Jahn, L, et al.
Publicado: (2014)

Parallel Sessions (Proffered Papers)
Publicado: (2010)

Parallel Sessions (Proffered Papers)
Publicado: (2008)

Part I: Abstracts of Members' Proffered Papers
Publicado: (1976)

Value of pretreatment MRI determined parameters for predicting outcome after radio-frequency ablation of hepatocellular carcinoma
por: Dresen, R, et al.
Publicado: (2015)

Proffering Connections: Psychologising Experience in Psychotherapy and Everyday Life
por: Ekberg, Stuart
Publicado: (2021)

B.A.C.R. Abstracts of member proffered papers
Publicado: (1980)

1703. Bacterial or Fungal Co-Infection in Patients with Mucormycosis
por: Choi, Sungim, et al.
Publicado: (2019)

PB1703: MODELING T-CELL DEVELOPMENT AND T-ALL INITIATION
por: Dick, Advaita M, et al.
Publicado: (2023)

G.T. Pickavance, M.G.N. Hine (left to right)
por: CERN PhotoLab
Publicado: (1962)

Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonist
por: Volz, Barbara, et al.
Publicado: (2016)

Letter sent by M.G.N. Hine to all ECFA members
por: European Committee for Future Accelerators
Publicado: (1968)

Present Status and Future Perspectives for Nisheathed $MGN_{2}$ Superconducting Tapes
por: Grasso, G, et al.
Publicado: (2005)

Distinctions of reason and reasonable distinctions: the academic life of John Wallis (1616-1703)
por: Rampelt, Jason M
Publicado: (2019)

Epidemiology of Tuberculosis During the Period 1703–2011: Honoring the World Tuberculosis Day
por: Santic, Zarko, et al.
Publicado: (2013)

P1703: ECONOMIC BURDEN OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN THE UNITED STATES
por: Udeze, C., et al.
Publicado: (2022)

Small RNA and transcriptome deep sequencing proffers insight into floral gene regulation in Rosa cultivars
por: Kim, Jungeun, et al.
Publicado: (2012)

Considerations on CERN Budgets for 1964-1967 (by Dr M.G.N. Hine)
Publicado: (1963)

Twenty-fifth annual general meeting of the British Association for Cancer Research. Abstracts of invited and profferred papers.
Publicado: (1984)

Long-Term Accelerator Programmes for CERN (Paper by Dr M.G.N. Hine)
Publicado: (1961)

Progress Report on the Status of the Neutrino Experiments at CERN (by G. Bernardini and M.G.N. Hine)
Publicado: (1961)

Progress Report on the Status of the Neutrino Experiments at CERN (by G. Bernardini and M.G.N. Hine)
Publicado: (1961)

Note on Beams and Beam Transport for the CERN PS 1961-63 (by M.G.N. Hine)
Publicado: (1961)

Aide-Memoire on 300 GeV Sites - May 1967 by M.G.N. Hine
Publicado: (1967)

Sextons' day books for 1685-1687 and 1694-1703 from the parish of St. Martin-in-the-Fields, London.
por: Forbes, T. R.
Publicado: (1973)

1703 Delta-like 1 ligand (DLL) measurement in cerebrospinal fluid for detection of Mycobacterium tuberculosis meningitis
por: Bahr, Nathan, et al.
Publicado: (2014)

Hypoxia and tumour angiogenesis involved in breast cancer progression and targets for therapy
por: Harris, AL
Publicado: (2000)

Speaker Schedule
Publicado: (2014)

Prenatal screening for Mendelian disorders in antenatal care
por: Verma, Amar
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ja0hct0v0u9imhkhckmvplrpb8